Your Bag

Your bag is empty.

undefined thumbnail image

GLP-3

£60.00

Sorry, this item is currently out of stock

GLP-3 is an investigational triple-hormone-receptor agonist ("triple G") targeting GLP-1, GIP, and glucagon receptors. Clinical trials show it delivers exceptional weight loss of up to 24% to 28% of body weight, deep abdominal and liver fat reductions, and improved blood sugar control.

Major Health Benefits

Substantial weight loss: Trials demonstrate average weight reduction surpassing 24–28% over extended dosing schedules, outperforming many dual or single-agonist alternatives.

Increased energy expenditure: Unlike drugs relying solely on appetite suppression, the inclusion of glucagon receptor activation helps ramp up calorie burning and fat metabolism.

Liver fat reduction: Early studies show dramatic decreases (up to 81–86%) in hepatic fat for individuals with metabolic-associated fatty liver disease.

Blood sugar and lipid control: Helps lower HbA1c in type 2 diabetes, aids prediabetes remission, and improves overall cardiovascular and blood lipid profiles.

Joint pain relief: Secondary trial measures noted decreased knee osteoarthritis pain and physical strain due to lowered body weight.